Skip to content

Study · Animal study (in vivo) · rat · 2010

6 results

High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736).

Ilic S, Drmic D, Zarkovic K, Kolenc D, Coric M, Brcic L, Klicek R, Radic B, Sever M, Djuzel V, Ivica M, Boban Blagaic A and 7 more

Show all authors

Zoricic Z, Anic T, Zoricic I, Djidic S, Romic Z, Seiwerth S, Sikiric P

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society1 Apr 2010Cited by 54 (Europe PMC)

PMID20436226 (opens in a new tab)PepBankPUB-20436226

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study6

6 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats given extreme paracetamol overdose, prophylactic BPC‑157 prevented convulsions.

    In plain wordsIn rats given a paracetamol overdose, BPC‑157 given right away prevented convulsions.

    Peptide
    BPC-157
    Outcome
    DecreaseGeneralized convulsions (prophylactic BPC 157)
    Study

    ratn: not reported in source

    Paracetamol overdose (5 g/kg intraperitoneally)
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    10 µg, 10 ng, 10 pg/kg · intraperitoneal or intragastricAs given in this study (rat).

    Source sentences

    Summary
    no convulsions (prophylactic application)
    1 context sentence
    Summary · context
    BPC 157 therapy (10 microg, 10 ng, 10 pg/kg, intraperitoneally or intragastrically) was effective (microg-ng range) against paracetamol toxicity, given in early (BPC 157 immediately after paracetamol, prophylactically) or advanced stage (BPC 157 at 3 hours after paracetamol, therapeutically).
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In rats given extreme paracetamol overdose, therapeutic BPC‑157 made convulsions disappear rapidly, within 25 minutes.

    In plain wordsIn rats given a paracetamol overdose, BPC‑157 given later stopped convulsions quickly, within 25 minutes.

    Peptide
    BPC-157
    Outcome
    DecreaseGeneralized convulsions (therapeutic BPC 157)
    Study

    ratn: not reported in source

    Paracetamol overdose (5 g/kg intraperitoneally)
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    10 µg, 10 ng, 10 pg/kg · intraperitoneal or intragastricAs given in this study (rat).

    Measurements

    Time to convulsion disappearance
    ≤ 25 min
    therapeutic BPC 157

    Source sentences

    Summary
    convulsions rapidly disappeared (therapeutic effect within 25 min)
    1 context sentence
    Summary · context
    BPC 157 therapy (10 microg, 10 ng, 10 pg/kg, intraperitoneally or intragastrically) was effective (microg-ng range) against paracetamol toxicity, given in early (BPC 157 immediately after paracetamol, prophylactically) or advanced stage (BPC 157 at 3 hours after paracetamol, therapeutically).
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In rats given extreme paracetamol overdose, BPC‑157 gave markedly less liver lesions on microscopy.

    In plain wordsIn rats given a paracetamol overdose, BPC‑157 led to much less liver damage under the microscope.

    Peptide
    BPC-157
    Outcome
    DecreaseLiver lesions (microscopical)
    Study

    ratn: not reported in source

    Paracetamol overdose (5 g/kg intraperitoneally)
    Outcome group
    Liver fat and liver function · Liver
    Studied dose
    10 µg, 10 ng, 10 pg/kg · intraperitoneal or intragastricAs given in this study (rat).

    Source sentences

    Summary
    microscopical (markedly less liver and brain lesions
    1 context sentence
    Summary · context
    BPC 157 therapy (10 microg, 10 ng, 10 pg/kg, intraperitoneally or intragastrically) was effective (microg-ng range) against paracetamol toxicity, given in early (BPC 157 immediately after paracetamol, prophylactically) or advanced stage (BPC 157 at 3 hours after paracetamol, therapeutically).
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In rats given extreme paracetamol overdose, BPC‑157 gave markedly less brain lesions on microscopy.

    In plain wordsIn rats given a paracetamol overdose, BPC‑157 led to much less brain damage under the microscope.

    Peptide
    BPC-157
    Outcome
    DecreaseBrain lesions (microscopical)
    Study

    ratn: not reported in source

    Paracetamol overdose (5 g/kg intraperitoneally)
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    10 µg, 10 ng, 10 pg/kg · intraperitoneal or intragastricAs given in this study (rat).

    Source sentences

    Summary
    microscopical (markedly less liver and brain lesions
    1 context sentence
    Summary · context
    BPC 157 therapy (10 microg, 10 ng, 10 pg/kg, intraperitoneally or intragastrically) was effective (microg-ng range) against paracetamol toxicity, given in early (BPC 157 immediately after paracetamol, prophylactically) or advanced stage (BPC 157 at 3 hours after paracetamol, therapeutically).
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In rats given extreme paracetamol overdose, BPC‑157 decreased serum levels of liver enzymes.

    In plain wordsIn rats given a paracetamol overdose, BPC‑157 lowered blood levels of liver enzymes.

    Peptide
    BPC-157
    Outcome
    DecreaseLiver enzyme serum levels (ALT, AST)
    Study

    ratn: not reported in source

    Paracetamol overdose (5 g/kg intraperitoneally)
    Outcome group
    Liver fat and liver function · Liver
    Studied dose
    10 µg, 10 ng, 10 pg/kg · intraperitoneal or intragastricAs given in this study (rat).

    Source sentences

    Summary
    biochemical (enzyme and ammonium serum levels decreased
    2 context sentences
    Summary · context
    increased ALT, AST and ammonium serum values precede liver lesion while in several brain areas, significant damage became apparent, accompanied by generalized convulsions.
    Summary · context
    BPC 157 therapy (10 microg, 10 ng, 10 pg/kg, intraperitoneally or intragastrically) was effective (microg-ng range) against paracetamol toxicity, given in early (BPC 157 immediately after paracetamol, prophylactically) or advanced stage (BPC 157 at 3 hours after paracetamol, therapeutically).
  6. 06AnimalAnimal study (in vivo)Efficacy outcome

    In rats given extreme paracetamol overdose, BPC‑157 decreased serum ammonium levels.

    In plain wordsIn rats given a paracetamol overdose, BPC‑157 lowered blood ammonium levels.

    Peptide
    BPC-157
    Outcome
    DecreaseAmmonium serum level
    Study

    ratn: not reported in source

    Paracetamol overdose (5 g/kg intraperitoneally)
    Outcome group
    Liver fat and liver function · Liver
    Studied dose
    10 µg, 10 ng, 10 pg/kg · intraperitoneal or intragastricAs given in this study (rat).

    Source sentences

    Summary
    biochemical (enzyme and ammonium serum levels decreased
    1 context sentence
    Summary · context
    BPC 157 therapy (10 microg, 10 ng, 10 pg/kg, intraperitoneally or intragastrically) was effective (microg-ng range) against paracetamol toxicity, given in early (BPC 157 immediately after paracetamol, prophylactically) or advanced stage (BPC 157 at 3 hours after paracetamol, therapeutically).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    9 Oct 2026, 18:17 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:56 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.